[go: up one dir, main page]

AU2002212102A1 - A process for production of particles for pharmaceutical compositions having increased bioavailability - Google Patents

A process for production of particles for pharmaceutical compositions having increased bioavailability

Info

Publication number
AU2002212102A1
AU2002212102A1 AU2002212102A AU1210202A AU2002212102A1 AU 2002212102 A1 AU2002212102 A1 AU 2002212102A1 AU 2002212102 A AU2002212102 A AU 2002212102A AU 1210202 A AU1210202 A AU 1210202A AU 2002212102 A1 AU2002212102 A1 AU 2002212102A1
Authority
AU
Australia
Prior art keywords
particles
production
pharmaceutical compositions
increased bioavailability
bioavailability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212102A
Inventor
Ove Emil Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEA Aseptomag AG
Original Assignee
Aeromatic Fielder AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeromatic Fielder AG filed Critical Aeromatic Fielder AG
Publication of AU2002212102A1 publication Critical patent/AU2002212102A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002212102A 2000-11-08 2001-10-29 A process for production of particles for pharmaceutical compositions having increased bioavailability Abandoned AU2002212102A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70796600A 2000-11-08 2000-11-08
US09/707,966 2000-11-08
PCT/DK2001/000715 WO2002038126A2 (en) 2000-11-08 2001-10-29 A process for production of particles for pharmaceutical compositions having increased bioavailability

Publications (1)

Publication Number Publication Date
AU2002212102A1 true AU2002212102A1 (en) 2002-05-21

Family

ID=24843867

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212102A Abandoned AU2002212102A1 (en) 2000-11-08 2001-10-29 A process for production of particles for pharmaceutical compositions having increased bioavailability

Country Status (2)

Country Link
AU (1) AU2002212102A1 (en)
WO (1) WO2002038126A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying active ingredient formulation and use of this formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
US8207232B2 (en) * 2004-05-28 2012-06-26 Bend Research, Inc. Pharmaceutical compositions with enhanced performance
CA2810655C (en) 2004-06-24 2013-12-10 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
DK1993360T3 (en) 2005-12-28 2017-05-22 Vertex Pharma SOLID FORMS OF N- [2,4-BIS (1,1-DIMETHYLETHYL) -5-HYDROXYPHENYL] -1,4-DIHYDRO-4-OXOQUINOLIN-3-CARBOXAMIDE
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
HRP20151137T1 (en) 2009-03-20 2015-11-20 Vertex Pharmaceuticals Incorporated PROCEDURE FOR OBTAINING TRANSMEMBRANE CONTROLLER OF CYSTIC FIBROSE CONDUCTIVITY
KR101807338B1 (en) 2010-06-14 2018-01-10 다우 글로벌 테크놀로지스 엘엘씨 Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
US9084727B2 (en) 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces
IL265430B2 (en) 2012-02-27 2024-08-01 Vertex Pharma Pharmaceutical preparations containing a solid dispersion of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide and uses thereof
CN107250113B (en) 2014-10-07 2019-03-29 弗特克斯药品有限公司 Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2528706B2 (en) * 1988-05-30 1996-08-28 ゼリア新薬工業株式会社 Pharmaceutical composition of dihydropyridine compound
GB9114374D0 (en) * 1991-07-03 1991-08-21 Smithkline Beecham Plc Novel process
EP0741603B1 (en) * 1994-01-27 1998-12-23 Aeromatic-Fielder AG An apparatus for coating solid particles
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
PT901786E (en) * 1997-08-11 2007-08-07 Pfizer Prod Inc Solid pharmaceutical dispersions with enhanced bioavailability
US6209479B1 (en) * 1998-12-30 2001-04-03 Aeromatic-Fielder Ag Apparatus for coating tablets

Also Published As

Publication number Publication date
WO2002038126A3 (en) 2002-10-10
WO2002038126A2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2001288175A1 (en) A process for the production of paper
AU2002220968A1 (en) Process for the preparation of a fast dissolving dosage form
AU2002212102A1 (en) A process for production of particles for pharmaceutical compositions having increased bioavailability
AU2001258276A1 (en) Process for the production of a deodorant or antiperspirant product
AU2002356755A1 (en) Process for production of detergent tablets
AU2002352353A1 (en) Process for production of styrene
AU6487600A (en) Process for production of an etheralcohol
AU2002354109A1 (en) Process for production of methionine
AU2464401A (en) Process for the preparation of oligomeric compounds
HRP20040161A2 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
AU2001240664A1 (en) Process for the production of methionine
AU2001277545A1 (en) Process for the production of 2-hydroxy-4-methylmercaptobutyric acid
AU2002353366A1 (en) The process of manufacturing a pharmaceutical composition useful for management of cancer
AU2001254719A1 (en) Process for the production of a titanium silicalite shaped article
AU2566100A (en) Process for the production of a nutritional composition
AU2003212351A1 (en) A process for the preparation of cephalosporan acid derivatives from cephalosporin c
AU2001274586A1 (en) Process for producing phospholipid-containing drugs
AU2002310898A1 (en) Process for the preparation of a polymer-amine
AU2002308986A1 (en) Process for preparation of a quinolinecarbaldehyde
AU2002302767A1 (en) Process for the preparation of a particulate material
AUPQ916700A0 (en) A method of preparing a pharmaceutical composition
AU2001264231A1 (en) Process for the preparation of a piperazine derivative
AU2002352423A1 (en) Process for the manufacture of pharmaceutically acceptable salts of a compound
AU2001248965A1 (en) The process for the production of a packing material
AU2001279511A1 (en) Process for obtaining a pharmaceutical composition